Annual long term liabilities:
$1.03B+$150.56M(+17.12%)Summary
- As of today (May 21, 2025), NVAX annual total long term liabilities is $1.03 billion, with the most recent change of +$150.56 million (+17.12%) on December 31, 2024.
- During the last 3 years, NVAX annual long term liabilities has risen by +$491.74 million (+91.38%).
- NVAX annual long term liabilities is now at all-time high.
Performance
NVAX Long term liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly long term liabilities:
$946.47M-$83.38M(-8.10%)Summary
- As of today (May 21, 2025), NVAX quarterly total long term liabilities is $946.47 million, with the most recent change of -$83.38 million (-8.10%) on March 31, 2025.
- Over the past year, NVAX quarterly long term liabilities has dropped by -$469.77 million (-33.17%).
- NVAX quarterly long term liabilities is now -33.17% below its all-time high of $1.42 billion, reached on March 31, 2024.
Performance
NVAX quarterly long term liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Long term liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
NVAX Long term liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +17.1% | -33.2% |
| 3 y3 years | +91.4% | +86.1% |
| 5 y5 years | +209.1% | +184.2% |
NVAX Long term liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +137.9% | -33.2% | +118.7% |
| 5 y | 5-year | at high | +209.1% | -33.2% | +184.2% |
| alltime | all time | at high | >+9999.0% | -33.2% | >+9999.0% |
NVAX Long term liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $946.47M(-8.1%) |
| Dec 2024 | $1.03B(+17.1%) | $1.03B(-2.7%) |
| Sep 2024 | - | $1.06B(-3.2%) |
| Jun 2024 | - | $1.09B(-22.9%) |
| Mar 2024 | - | $1.42B(+61.1%) |
| Dec 2023 | $879.28M(+103.2%) | $879.28M(+1.4%) |
| Sep 2023 | - | $866.92M(+2.8%) |
| Jun 2023 | - | $843.31M(+62.4%) |
| Mar 2023 | - | $519.42M(+20.0%) |
| Dec 2022 | $432.81M(-19.6%) | $432.81M(-62.9%) |
| Sep 2022 | - | $1.17B(+31.9%) |
| Jun 2022 | - | $883.70M(+73.8%) |
| Mar 2022 | - | $508.55M(-5.5%) |
| Dec 2021 | $538.11M(+43.3%) | $538.11M(+53.2%) |
| Sep 2021 | - | $351.19M(-0.4%) |
| Jun 2021 | - | $352.51M(-2.3%) |
| Mar 2021 | - | $360.68M(-4.0%) |
| Dec 2020 | $375.60M(+12.7%) | $375.60M(-37.2%) |
| Sep 2020 | - | $598.36M(+12.0%) |
| Jun 2020 | - | $534.37M(+60.4%) |
| Mar 2020 | - | $333.06M(-0.0%) |
| Dec 2019 | $333.18M(+0.8%) | $333.18M(+0.0%) |
| Sep 2019 | - | $333.07M(-0.1%) |
| Jun 2019 | - | $333.39M(-2.1%) |
| Mar 2019 | - | $340.41M(+3.0%) |
| Dec 2018 | $330.37M(-0.1%) | $330.37M(-0.0%) |
| Sep 2018 | - | $330.44M(-0.0%) |
| Jun 2018 | - | $330.50M(-0.0%) |
| Mar 2018 | - | $330.53M(-0.0%) |
| Dec 2017 | $330.55M(-0.9%) | $330.55M(-2.8%) |
| Sep 2017 | - | $339.95M(-2.3%) |
| Jun 2017 | - | $347.98M(+4.2%) |
| Mar 2017 | - | $334.11M(+0.2%) |
| Dec 2016 | $333.44M(+1875.9%) | $333.44M(-0.2%) |
| Sep 2016 | - | $334.16M(+0.3%) |
| Jun 2016 | - | $333.01M(-0.9%) |
| Mar 2016 | - | $336.02M(+1891.2%) |
| Dec 2015 | $16.88M(+37.6%) | $16.88M(+32.4%) |
| Sep 2015 | - | $12.74M(+26.9%) |
| Jun 2015 | - | $10.04M(-3.1%) |
| Mar 2015 | - | $10.36M(-15.6%) |
| Dec 2014 | $12.27M(-10.9%) | $12.27M(+0.3%) |
| Sep 2014 | - | $12.23M(-4.3%) |
| Jun 2014 | - | $12.78M(-7.5%) |
| Mar 2014 | - | $13.82M(+0.4%) |
| Dec 2013 | $13.77M(+32.0%) | $13.77M(-3.3%) |
| Sep 2013 | - | $14.24M(+14.5%) |
| Jun 2013 | - | $12.44M(+4.7%) |
| Mar 2013 | - | $11.88M(+13.9%) |
| Dec 2012 | $10.43M | $10.43M(+19.5%) |
| Sep 2012 | - | $8.73M(+34.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2012 | - | $6.48M(+0.1%) |
| Mar 2012 | - | $6.47M(+25.7%) |
| Dec 2011 | $5.15M(-6.9%) | $5.15M(-10.4%) |
| Sep 2011 | - | $5.75M(+40.9%) |
| Jun 2011 | - | $4.08M(-25.6%) |
| Mar 2011 | - | $5.48M(-0.9%) |
| Dec 2010 | $5.53M(-27.5%) | $5.53M(+97.9%) |
| Sep 2010 | - | $2.79M(-3.7%) |
| Jun 2010 | - | $2.90M(-3.5%) |
| Mar 2010 | - | $3.00M(-60.6%) |
| Dec 2009 | $7.63M(+123.0%) | $7.63M(+137.1%) |
| Sep 2009 | - | $3.22M(-2.8%) |
| Jun 2009 | - | $3.31M(-0.8%) |
| Mar 2009 | - | $3.34M(-2.4%) |
| Dec 2008 | $3.42M(-84.5%) | $3.42M(+6.8%) |
| Sep 2008 | - | $3.20M(-86.9%) |
| Jun 2008 | - | $24.53M(+11.0%) |
| Mar 2008 | - | $22.10M(+0.4%) |
| Dec 2007 | $22.02M(-2.3%) | $22.02M(-0.8%) |
| Sep 2007 | - | $22.21M(+0.3%) |
| Jun 2007 | - | $22.14M(-2.1%) |
| Mar 2007 | - | $22.60M(+0.3%) |
| Dec 2006 | $22.54M(-24.5%) | $22.54M(-0.4%) |
| Sep 2006 | - | $22.63M(-0.4%) |
| Jun 2006 | - | $22.71M(-0.3%) |
| Mar 2006 | - | $22.78M(-23.7%) |
| Dec 2005 | $29.85M(-17.4%) | $29.85M(-16.9%) |
| Sep 2005 | - | $35.94M(-0.1%) |
| Jun 2005 | - | $35.97M(-0.2%) |
| Mar 2005 | - | $36.05M(-0.2%) |
| Dec 2004 | $36.14M(-16.7%) | $36.14M(-0.2%) |
| Sep 2004 | - | $36.21M(-16.1%) |
| Jun 2004 | - | $43.17M(-0.2%) |
| Mar 2004 | - | $43.27M(-0.2%) |
| Dec 2003 | $43.38M(-0.4%) | $43.38M(-0.2%) |
| Sep 2003 | - | $43.48M(-0.3%) |
| Jun 2003 | - | $43.59M(-0.3%) |
| Mar 2003 | - | $43.75M(+0.4%) |
| Dec 2002 | $43.57M(+33.5%) | $43.57M(+2.7%) |
| Sep 2002 | - | $42.44M(-0.1%) |
| Jun 2002 | - | $42.50M(+30.5%) |
| Mar 2002 | - | $32.56M(-0.2%) |
| Dec 2001 | $32.63M(+63.1%) | $32.63M(-0.2%) |
| Sep 2001 | - | $32.69M(+43.7%) |
| Jun 2001 | - | $22.75M(+13.8%) |
| Mar 2001 | - | $20.00M(0.0%) |
| Dec 2000 | $20.00M(>+9900.0%) | $20.00M(>+9900.0%) |
| Dec 1999 | $100.00K(-200.0%) | $100.00K(0.0%) |
| Sep 1999 | - | $100.00K(-200.0%) |
| Dec 1998 | -$100.00K | -$100.00K(-200.0%) |
| Jun 1997 | - | $100.00K |
FAQ
- What is Novavax annual total long term liabilities?
- What is the all time high annual long term liabilities for Novavax?
- What is Novavax annual long term liabilities year-on-year change?
- What is Novavax quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Novavax?
- What is Novavax quarterly long term liabilities year-on-year change?
What is Novavax annual total long term liabilities?
The current annual long term liabilities of NVAX is $1.03B
What is the all time high annual long term liabilities for Novavax?
Novavax all-time high annual total long term liabilities is $1.03B
What is Novavax annual long term liabilities year-on-year change?
Over the past year, NVAX annual total long term liabilities has changed by +$150.56M (+17.12%)
What is Novavax quarterly total long term liabilities?
The current quarterly long term liabilities of NVAX is $946.47M
What is the all time high quarterly long term liabilities for Novavax?
Novavax all-time high quarterly total long term liabilities is $1.42B
What is Novavax quarterly long term liabilities year-on-year change?
Over the past year, NVAX quarterly total long term liabilities has changed by -$469.77M (-33.17%)